Literature DB >> 24676341

What matters most in pediatric familial hypercholesterolemia, genotype or phenotype?

Frederick J Raal1, Evan A Stein.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 24676341      PMCID： PMC3995455          DOI： 10.1194/jlr.E049585

Source DB:  PubMed          Journal:  J Lipid Res        ISSN： 0022-2275            Impact factor:   5.922


× No keyword cloud information.
  13 in total

1.  Expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents: summary report.

Authors: 
Journal:  Pediatrics       Date:  2011-11-14       Impact factor: 7.124

Review 2.  A systematic review and meta-analysis of statin therapy in children with familial hypercholesterolemia.

Authors:  H J Avis; M N Vissers; E A Stein; F A Wijburg; M D Trip; J J P Kastelein; B A Hutten
Journal:  Arterioscler Thromb Vasc Biol       Date:  2007-06-14       Impact factor: 8.311

3.  Use of low-density lipoprotein cholesterol gene score to distinguish patients with polygenic and monogenic familial hypercholesterolaemia: a case-control study.

Authors:  Philippa J Talmud; Sonia Shah; Ros Whittall; Marta Futema; Philip Howard; Jackie A Cooper; Seamus C Harrison; Kawah Li; Fotios Drenos; Frederik Karpe; H Andrew W Neil; Olivier S Descamps; Claudia Langenberg; Nicholas Lench; Mika Kivimaki; John Whittaker; Aroon D Hingorani; Meena Kumari; Steve E Humphries
Journal:  Lancet       Date:  2013-02-22       Impact factor: 79.321

4.  Measurement of apolipoprotein B as a screening test for identifying children with elevated levels of low-density lipoprotein cholesterol.

Authors:  B A Dennison; D A Kikuchi; S R Srinivasan; L S Webber; G S Berenson
Journal:  J Pediatr       Date:  1990-09       Impact factor: 4.406

5.  Apolipoprotein B as a marker of familial hyperlipoproteinemia.

Authors:  Tomas Sveger; Karin Nordborg
Journal:  J Atheroscler Thromb       Date:  2004       Impact factor: 4.928

6.  Arterial intima-media thickness in children heterozygous for familial hypercholesterolaemia.

Authors:  Albert Wiegman; Eric de Groot; Barbara A Hutten; Jessica Rodenburg; Johan Gort; Henk D Bakker; Eric J G Sijbrands; John J P Kastelein
Journal:  Lancet       Date:  2004-01-31       Impact factor: 79.321

7.  Cardiovascular risk assessment of dyslipidemic children: analysis of biomarkers to identify monogenic dyslipidemia.

Authors:  Ana Margarida Medeiros; Ana Catarina Alves; Pedro Aguiar; Mafalda Bourbon
Journal:  J Lipid Res       Date:  2014-03-13       Impact factor: 5.922

8.  Relation of cholesterol-year score to severity of calcific atherosclerosis and tissue deposition in homozygous familial hypercholesterolemia.

Authors:  H H Schmidt; S Hill; E V Makariou; I M Feuerstein; K A Dugi; J M Hoeg
Journal:  Am J Cardiol       Date:  1996-03-15       Impact factor: 2.778

9.  Efficacy and safety of lovastatin in adolescent males with heterozygous familial hypercholesterolemia: a randomized controlled trial.

Authors:  E A Stein; D R Illingworth; P O Kwiterovich; C A Liacouras; M A Siimes; M S Jacobson; T G Brewster; P Hopkins; M Davidson; K Graham; F Arensman; R H Knopp; C DuJovne; C L Williams; J L Isaacsohn; C A Jacobsen; P M Laskarzewski; S Ames; G J Gormley
Journal:  JAMA       Date:  1999-01-13       Impact factor: 56.272

10.  Low-density lipoprotein receptor gene familial hypercholesterolemia variant database: update and pathological assessment.

Authors:  Ebele Usifo; Sarah E A Leigh; Ros A Whittall; Nicholas Lench; Alison Taylor; Corin Yeats; Christine A Orengo; Andrew C R Martin; Jacopo Celli; Steve E Humphries
Journal:  Ann Hum Genet       Date:  2012-09       Impact factor: 1.670
View more
  1 in total

Review 1.  The genetics and screening of familial hypercholesterolaemia.

Authors:  Raymond Henderson; Maurice O'Kane; Victoria McGilligan; Steven Watterson
Journal:  J Biomed Sci       Date:  2016-04-16       Impact factor: 8.410
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.